Progesterone plays several roles during menopause, from protecting the uterine lining when you take estrogen therapy to improving sleep quality and supporting bone health. Its most essential function is preventing the overgrowth of uterine tissue that unopposed estrogen can cause, but its benefits extend well beyond that single job.
Why Progesterone Is Added to Estrogen Therapy
If you have a uterus and take estrogen to manage menopause symptoms, progesterone is a necessary partner. Estrogen on its own stimulates the uterine lining to thicken. Without something to counteract that growth, the lining can develop abnormal changes (endometrial hyperplasia) that raise the risk of uterine cancer over time. Progesterone triggers the lining to shed or stabilize, keeping that risk in check. This is why every major menopause society recommends adding a progestogen for women with an intact uterus who use estrogen therapy.
The standard approach is 200 mg of oral micronized progesterone taken at bedtime for 12 days out of each 28-day cycle. This cyclical regimen mimics the natural hormonal pattern your body used before menopause, prompting a withdrawal bleed similar to a light period. Some women use a continuous daily dose instead, which typically eliminates monthly bleeding after an initial adjustment period. Your prescriber will tailor the regimen based on how far you are past menopause and your preference around bleeding.
How It Helps With Sleep
One of the most noticeable effects of oral progesterone is drowsiness, which is why it’s taken at bedtime. This isn’t a side effect so much as a built-in feature. When your body breaks down progesterone, it produces a metabolite called allopregnanolone. This compound acts on the same brain receptors that anti-anxiety and sleep medications target: GABA-A receptors, which calm neural activity. The result is a mild sedative effect that can help you fall asleep faster and spend more time in restorative non-REM sleep.
For many menopausal women, sleep disruption is one of the most debilitating symptoms. Night sweats play a role, but shifting hormone levels also directly affect sleep architecture. The calming action of progesterone’s metabolites addresses both problems at once: it promotes deeper sleep while also carrying anxiolytic (anxiety-reducing) properties. In studies, a single 300 mg dose of oral micronized progesterone produced sleep changes in line with what you’d expect from a conventional GABA-targeting sleep aid, including increased non-REM sleep.
Effects on Hot Flashes and Night Sweats
Progesterone alone can modestly reduce hot flashes, though the evidence is less robust than for estrogen. In a randomized, placebo-controlled trial (the PROGEST study), postmenopausal women with severe vasomotor symptoms (more than 50 hot flashes per week) took 200, 300, or 400 mg of progesterone daily for 12 weeks. All three doses showed a slight dose-dependent improvement over placebo: women on the highest dose experienced a reduction of about 9 hot flashes per day compared to 7.4 per day with placebo. The trial was small and underpowered due to enrollment challenges, so these numbers should be interpreted cautiously, but the trend was consistent across doses without an increase in side effects.
This makes progesterone a potential option for women who cannot take estrogen, such as those with certain clotting risks. It won’t match the symptom relief of combined hormone therapy, but it offers a meaningful reduction for some women.
Supporting Bone Health
Estrogen is well established as the primary hormonal protector against bone loss after menopause. It works mainly by slowing bone breakdown. Progesterone appears to complement this from the other side of the equation: stimulating the cells that build new bone (osteoblasts).
Lab studies show that physiological levels of progesterone increase osteoblast differentiation in a dose-dependent manner. After 21 days of exposure to normal progesterone concentrations, markers of bone-building activity increased 2.7-fold. Interestingly, this effect was independent of estrogen, meaning progesterone doesn’t need estrogen present to stimulate bone formation. However, supraphysiological (above-normal) concentrations actually suppressed osteoblast activity, which underscores the importance of appropriate dosing. The combination of estrogen reducing bone resorption and progesterone promoting bone formation suggests the two hormones work as a team in maintaining skeletal strength.
Cardiovascular Safety Profile
One of the key advantages of micronized progesterone over older synthetic progestins is its neutral cardiovascular profile. A three-month randomized, placebo-controlled trial of 133 healthy postmenopausal women found that 300 mg daily of progesterone produced no significant changes in blood pressure, resting heart rate, weight, waist circumference, total cholesterol, LDL cholesterol, triglycerides, fasting glucose, or markers of inflammation and blood clotting compared to placebo. Overall cardiovascular risk scores remained low and unchanged.
There was a small, statistically significant decrease in HDL cholesterol (the “good” cholesterol), but it wasn’t large enough to shift overall cardiovascular risk. By comparison, older synthetic progestins like medroxyprogesterone acetate have a more pronounced negative effect on HDL levels. This favorable profile is one reason clinicians increasingly prefer micronized progesterone for hormone therapy.
Micronized Progesterone vs. Synthetic Progestins
Not all progestogens are the same, and this distinction matters most when it comes to breast cancer risk. Pooled analyses have found that when combined with estrogen, micronized progesterone is associated with a relative risk of 0.67 for breast cancer compared to synthetic progestins. That translates to roughly a 33% lower risk. This difference, reported by the International Menopause Society, has shifted clinical practice in many countries toward micronized progesterone as the preferred option.
The distinction comes down to molecular structure. Micronized progesterone is chemically identical to the progesterone your ovaries produced before menopause. Synthetic progestins like medroxyprogesterone acetate and norethindrone have different molecular shapes that interact with a broader range of receptors, potentially explaining their less favorable safety profile. “Micronized” simply means the hormone has been ground into tiny particles to improve absorption when taken orally.
Common Side Effects
The sedative quality that helps with sleep can also cause morning grogginess if the dose is too high or taken too late. Taking it right at bedtime and starting at the standard 200 mg dose minimizes this. Some women experience bloating, breast tenderness, or mood changes, particularly during the first few cycles. These effects are generally mild and tend to settle as your body adjusts.
Vaginal progesterone (gels or suppositories) is an alternative route that delivers the hormone directly to the uterus with lower systemic absorption. This can reduce side effects like drowsiness but also means you lose some of the sleep and anxiety benefits that come from progesterone’s metabolites circulating through your bloodstream. A hormonal IUD that releases a progestin locally is another option that protects the uterine lining while minimizing whole-body effects.